Qualitative plasma PCR (AMPLICOR CMV) vs pp65 antigenemia (AG) for monitoring active cytomegalovirus (CMV) infection and pre-emptive ganciclovir therapy after allogeneic peripheral blood stem cell transplantation (Allo-PBT).

被引：0
|
作者：
Solano, C [1 ]
Gutierrez, A [1 ]
Munoz, I [1 ]
Navarro, D [1 ]
Garcia-Clavel, B [1 ]
Teruel, I [1 ]
Gomez, C [1 ]
Gimeno, C [1 ]
Garcia-Conde, J [1 ]
机构：
[1] Univ Valencia, Hosp Clin, Valencia, Spain
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1658
引用
收藏
页码：394A / 394A
页数：1
相关论文
共 39 条
  • [1] Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation
    Solano, C
    Muñoz, I
    Gutiérrez, A
    Farga, A
    Prósper, F
    García-Conde, J
    Navarro, D
    Gimeno, C
    JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) : 3938 - 3941
  • [2] Pre-emptive therapy with valganciclovir for cytomegalovirus (CMV) infection after allogeneic haematopoietic stem cell transplantation (Allo-HSCT)
    Topcuoglu, P.
    Arslan, O.
    Ozcan, M.
    Ilhan, O.
    Akan, H.
    Uysal, A.
    Gurman, G.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S322 - S323
  • [3] Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation
    Boivin, G
    Bélanger, R
    Delage, R
    Béliveau, C
    Demers, C
    Goyette, N
    Roy, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (12) : 4356 - 4360
  • [4] Qualitative plasma PCR assay versus pp65 antigenemia assay for monitoring CMV infection and preemptive ganciclovir/foscavir therapy in allogeneic hematopoietic stem cell transplantation: single center experience
    Zawilinska, B
    Hawrylecka, D
    Mensah, P
    Skotnicki, AB
    BONE MARROW TRANSPLANTATION, 2003, 31 : S90 - S90
  • [5] Pre-emptive therapy against cytomegalovirus (CMV) diseases guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation.
    Ohnishi, M
    Kanda, Y
    Saito, T
    Niiya, H
    Nakai, K
    Takeuchi, T
    Tanosaki, R
    Kunitoh, H
    Kobayashi, Y
    Tobinai, K
    Mineishi, S
    Takaue, Y
    BLOOD, 2000, 96 (11) : 342B - 342B
  • [6] Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience
    Manteiga, R
    Martino, R
    Sureda, A
    Labeaga, R
    Brunet, S
    Sierra, J
    Rabella, N
    BONE MARROW TRANSPLANTATION, 1998, 22 (09) : 899 - 904
  • [7] Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience
    R Manteiga
    R Martino
    A Sureda
    R Labeaga
    S Brunet
    J Sierra
    N Rabella
    Bone Marrow Transplantation, 1998, 22 : 899 - 904
  • [8] Qualitative plasma PCR assay versus pp65 antigenemia (AG) assay for monitoring CMV infection and preemptive ganciclovir/foscavir therapy in allogeneic hematopoietic stem cell transplantation (HSCT)-single center experience.
    Piatkowska-Jakubas, BB
    Zawilinska, B
    Mensah, P
    Hawrylecka, D
    Krawczyk, J
    Skotnicki, AB
    BLOOD, 2003, 102 (11) : 440B - 440B
  • [9] Cidofovir (CDV) as prophylaxis and pre-emptive therapy of Cytomegalovirus (CMV) infection in allogeneic stem cell transplantation
    Cudillo, L
    Dentamaro, T
    Postorino, M
    Picardi, A
    Rainaldi, A
    Cupelli, L
    De Laurenzi, F
    Di Caro, A
    Amadori, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S153 - S153
  • [10] CMV-monitoring after peripheral blood stem cell transplantation by pp65 antigen and quantitative PCR
    Schulenburg, A
    Watkins-Riedel, T
    Kalhs, P
    Knöbl, P
    Keil, F
    Rabitsch, W
    Mitterbauer, M
    Loidolt, H
    Greinix, HT
    BONE MARROW TRANSPLANTATION, 2001, 27 : S156 - S156
1234